MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced the publication of data showing that use of its Reveal ® family of Insertable Cardiac Monitors led to diagnosis and specific ...
Please provide your email address to receive an email when new articles are posted on . Immediate insertion of a cardiac monitor following first cryptogenic stroke was cost-effective in the U.S.
MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced the publication of results from a multicenter, prospective study that demonstrated that the company’s Reveal ® Plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results